NDAINJECTIONINJECTABLEPriority Review
Approved
Mar 1949
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
Priority Review
MUSTARGEN (mechlorethamine hydrochloride) by Recordati is alkylating activity [moa]. Approved for alkylating drug [epc]. First approved in 1949.
Drug data last refreshed 1h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MUSTARGEN (mechlorethamine hydrochloride) is a classical alkylating agent administered by injection used to treat hematologic malignancies and mycosis fungoides. It works through direct DNA alkylation, cross-linking DNA strands to inhibit tumor cell proliferation. This vintage chemotherapy represents a foundational mechanism in oncology with decades of clinical utility.
LOE Approaching
As LOE approaches with moderate competitive pressure (30/100), MUSTARGEN brand teams face resource constraints and likely transition toward lifecycle management, maintenance, and possible divestiture discussions.
Mechanism of Action
Alkylating Activity
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
MUSTARGEN offers limited upside career opportunities given its LOE-approaching status and zero linked job count; roles are primarily defensive and focused on maximizing mature-phase revenue and managing generic transition. This profile suits professionals seeking stabilization assignments, turnaround experience, or specialty oncology expertise rather than growth-track positions.
Brand Manager (Generic Defense)Sales Director (Hospital/Specialty Oncology)
Worked on MUSTARGEN at Recordati? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.